Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Nilay Ermantas"'
Autor:
Nergiz Erkut, Ahmet Menteşe, Hasan Mücait Özbaş, Nilay Ermantaş, Ayşegül Sümer, Asım Örem, Mehmet Sönmez
Publikováno v:
Turkish Journal of Hematology, Vol 33, Iss 2, Pp 135-140 (2016)
INTRODUCTION: The soluble urokinase plasminogen activator receptor (suPAR) is a soluble form of the urokinase plasminogen activator receptor expressed in various immune and cancer cells. The levels of suPAR have been demonstrated to correlate with pr
Externí odkaz:
https://doaj.org/article/1933ecad603c4303add7ae80d22b7405
Publikováno v:
Turkish Journal of Hematology, Vol 31, Iss 4, Pp 437-438 (2014)
Externí odkaz:
https://doaj.org/article/a0557ec9f6284869b2779a43201c2726
Autor:
Orbay Harmandar, Gülsüm Emel Pamuk, Ferda Harmandar, Nilay Ermantas, Muzaffer Demir, Özden Vural, Burhan Turgut
Publikováno v:
Annals of Hematology. 87:305-310
We aimed to evaluate the prevalences of self-reported anxiety and depression symptoms in hematological malignancy patients and to determine the association between the presence of these disorders and the results of the European Organization for Resea
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dbd3e07f220c79d65b991b226fb12f91
https://doi.org/10.1007/s00277-008-0445-4
https://doi.org/10.1007/s00277-008-0445-4
Autor:
Mehmet Soy, Ömür Ökten, Müşerref Tatman Oktun, Gündeniz Altınay, Burhan Turgut, Nilay Ermantas, Nermin Tuncbilek
Publikováno v:
Rheumatology International. 26:461-464
Antiphospholipid syndrome is an autoimmune disease that is characterised by tendency to thrombosis, obstetrical and hematological complications. Corticosteroids may be useful for therapy of some features of this syndrome, such as thrombocytopenia. No
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f987475a047a3bed2b6785cea7fb02c1
https://doi.org/10.1007/s00296-005-0014-2
https://doi.org/10.1007/s00296-005-0014-2
Publikováno v:
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis. 16(5)
Hypothyroidism causes a tendency for cardiovascular diseases. It was recently shown that thrombin-activatable fibrinolysis inhibitor (TAFI) attenuates fibrinolysis and also fibrin-plasminogen interaction by the removal of lysine and arginine residues
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e780e3b6624e405f34e3d1c54cab0b40
https://pubmed.ncbi.nlm.nih.gov/19959491
https://pubmed.ncbi.nlm.nih.gov/19959491